Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman
123456789
Next »

Passion, Innovation, and Loss

At a time when the industry is struggling with innovation, it might do well to learn a lesson from a few great innovators.
Nov 2, 2011
By: Michelle Hoffman

At a time when the industry is struggling with innovation, it might do well to learn a lesson from a few great innovators.

Retrospection and Introspection at FDA

A report commissioned by FDA evaluates the QbD program.
Sep 2, 2011
By: Michelle Hoffman

A report commissioned by FDA evaluates the QbD program.

Biosimilars or Bust

Are biosimilars the next big thing or just the next big bubble?
Aug 2, 2011
By: Michelle Hoffman

Are biosimilars the next big thing or just the next big bubble?

Legislation v. Litigation

Which route will we take to arrive at a national stem-cell policy?
Jul 2, 2011
By: Michelle Hoffman

Which route will we take to arrive at a national stem-cell policy?

Perception and Reality

Those who doubt there's faith in science, should check out our annual Bioprocessing Survey.
May 2, 2011
By: Michelle Hoffman

Those who doubt there's faith in science, should check out our annual Bioprocessing Survey.

Bioprocessing Trends: Annual Survey

Results from our annual survey. This article contains online bonus material and is part of a special issue on Bioprocessing and Sterile Manufacturing.
May 1, 2011
By: Michelle Hoffman

Results from our annual survey. This article contains online bonus material and is part of a special issue on Bioprocessing and Sterile Manufacturing.

Celebrity Couples to Disunite

Research and development may be headed for divorce.
Apr 2, 2011
By: Michelle Hoffman

Research and development may be headed for divorce.

Follow-Ons: The New Black?

Follow-ons were all the rage at this year's JP Morgan Healthcare Conference.
Feb 2, 2011
By: Michelle Hoffman

Follow-ons were all the rage at this year's JP Morgan Healthcare Conference.

What a Piece of Work is Pharma

Capable of great works, pharma as a whole still yields to the lesser angels of its nature.
Jan 2, 2011
By: Michelle Hoffman

Capable of great works, pharma as a whole still yields to the lesser angels of its nature.

123456789
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
67%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
33%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here